Eligibility for Cardiovascular Risk Reduction Therapy in the U.S. Based on SELECT Trial Criteria: Insights from the National Health and Nutrition Examination Survey

By sjmartinez • November 12, 2023

Lu Y, Liu Y, Jastreboff AM, Khera R, Ndumele CD, Rodriguez F, Watson KE, Krumholz HM. Eligibility for Cardiovascular Risk Reduction Therapy in the U.S. Based on SELECT Trial Criteria: Insights from the National Health and Nutrition Examination Survey. Circ Cardiovasc Qual Outcomes. 2023 Nov 11. doi: 10.1161/CIRCOUTCOMES.123.010640. Epub ahead of print. PMID: 37950677.

Tags: Cardiology/Epi, Publications

Transcatheter epicardial pacing of the human Bachmann’s bundle via the transverse sinus: Novel technique to expand transcatheter cardiac intervention

Miyazaki Y, Mori S, Rimmer M, Tholakanahalli V. Transcatheter epicardial pacing of the human Bachmann's bundle via the transverse sinus: Novel technique to expand transcatheter[...]

Device-Specific Outcomes of Percutaneous Mechanical Aspiration in Right-Sided Infective Endocarditis: Insights From the Multicenter CLEAR-IE Registry

Robinson G, Heybati K, Hibbert B, Bangalore S, Fong P, Zlotnick D, Zwischenberger B, Sayfo S, Younes S, Ingrassia J, Hammadah M, Prasad A, Hamid[...]

Deep Learning-derived Bone Mineral Density and Longitudinal White Matter Microstructure and Cognitive Decline: Multi-Ethnic Study of Atherosclerosis

Momtazmanesh S, Hathaway QA, Bancks MP, Bluemke DA, Barr RG, Post WS, Habes M, Nasrallah I, Heckbert SR, Bryan RN, Luchsinger JA, Wan M, Budoff[...]